Publication details

Latest Updates on Lipid Management

Authors

EGOM Emmanuel Eroume-A. PHARITHI Rebabonye B. HESSE Soressa STARR Neasa ARMSTRONG Richard SULAIMAN Habitha Mohammed GAZDIKOVA Katarina MOZOS Ioana CAPRNDA Martin KUBATKA Peter KRUŽLIAK Peter KHAN Barkat GASPAR Ludovit MAHER Vincent M. G.

Year of publication 2019
Type Article in Periodical
Magazine / Source HIGH BLOOD PRESSURE & CARDIOVASCULAR PREVENTION
MU Faculty or unit

Faculty of Medicine

Citation
Web http://dx.doi.org/10.1007/s40292-019-00306-8
Doi http://dx.doi.org/10.1007/s40292-019-00306-8
Keywords ASCVD; Atherosclerotic cardiovascular disease; Cholesterol; Lipid management; Triglycerides
Description Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of death worldwide. Despite the clinical long-term and near-term benefits of lowering cholesterol in, respectively, primary and secondary prevention of ASCVD, cholesterol levels remain under-treated, with many patients not achieving their recommended targets. The present article will review the latest updates on lipid management with emphases on the different classes of cholesterol-lowering agents and their clinical uses.

You are running an old browser version. We recommend updating your browser to its latest version.

More info